Identification of an EGCG oxidation derivative with proteasome modulatory activity

Biochimie

Volumn 93, Issue 5, 2011, Pages 931-940

  Bonfili, Laura ^a   Cuccioloni, Massimiliano ^a   Mozzicafreddo, Matteo ^a   Cecarini, Valentina ^a   Angeletti, Mauro ^a   Eleuteri, Anna Maria ^a  

^a UNIVERSITY OF CAMERINO   (Italy)

Author keywords

EGCG; HeLa cells; Molecular docking; Proteasome; Ring fission oxidation product

Indexed keywords

ACETYL COENZYME A ACETYLTRANSFERASE; ACYL COA OXIDASE 1; ACYL COENZYME A OXIDASE; CARBON 14; CATALASE; CHOLESTEROL; LATHOSTEROL; MESSENGER RNA; MULTIFUNCTIONAL PROTEIN 1; MULTIFUNCTIONAL PROTEIN 2; PALMITIC ACID; PEROXISOMAL 3 KETOACYL COENZYME A THIOLASE B; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR ALPHA; PIRINIXIC ACID; PROTEIN; STEROL REGULATORY ELEMENT BINDING PROTEIN 2; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL LEVEL; CELLULAR DISTRIBUTION; CHOLESTEROL BLOOD LEVEL; CHOLESTEROL SYNTHESIS; CONTROLLED STUDY; ELECTRON MICROSCOPY; ENZYME ACTIVITY; FATTY ACID OXIDATION; GENE EXPRESSION REGULATION; INTRACELLULAR SIGNALING; ISOTOPE LABELING; LIVER; LIVER MITOCHONDRION; MALE; MITOCHONDRIAL RESPIRATION; MOUSE; NONHUMAN; PEROXISOME; UPREGULATION; WILD TYPE;

ANTIOXIDANTS; CATECHIN; CELL SURVIVAL; COMPUTER SIMULATION; DRUG STABILITY; HELA CELLS; HUMANS; MODELS, MOLECULAR; MOLECULAR STRUCTURE; OXIDATION-REDUCTION; PROTEASOME ENDOPEPTIDASE COMPLEX; PROTEIN BINDING; PROTEIN CARBONYLATION; PROTEINS; SURFACE PROPERTIES; UBIQUITINATION;

EID: 79953888335     PISSN: 03009084     EISSN: 61831638     Source Type: Journal    
DOI: 10.1016/j.biochi.2011.02.003     Document Type: Article

References (57)

1. B.P. Tu, A. Kudlicki, M. Rowicka, S.L. McKnight, Logic of the yeast metabolic cycle: temporal compartmentalization of cellular processes, Science 310 (2005) 1152-1158. (Pubitemid 41681736)
2. W.C. Burhans, N.H. Heintz, The cell cycle is a redox cycle: linking phase-specific targets to cell fate, Free Radic. Biol. Med. (2009).
3. R.G. Jones, C.B. Thompson, Tumor suppressors and cell metabolism: a recipe for cancer growth, Genes Dev. 23 (2009) 537-548.
4. S.J. Thompson, L.T. Loftus, M.D. Ashley, R. Meller, Ubiquitin-proteasome system as a modulator of cell fate, Curr. Opin. Pharmacol. 8 (2008) 90-95. (Pubitemid 351168692)
5. M. Groll, M. Bochtler, H. Brandstetter, T. Clausen, R. Huber, Molecular machines for protein degradation, Chembiochem 6 (2005) 222-256. (Pubitemid 40879733)
6. M. Orlowski, S. Wilk, Catalytic activities of the 20 S proteasome, a multi-catalytic proteinase complex, Arch. Biochem. Biophys. 383 (2000) 1-16.
7. P.M. Kloetzel, A. Soza, R. Stohwasser, The role of the proteasome system and the proteasome activator PA28 complex in the cellular immune response, Biol. Chem. 380 (1999) 293-297.
8. M.S. Chen, D. Chen, Q.P. Dou, Inhibition of proteasome activity by various fruits and vegetables is associated with cancer cell death, In Vivo 18 (2004) 73-80. (Pubitemid 38263375)
9. L. Bonfili, V. Cecarini, M. Amici, M. Cuccioloni, M. Angeletti, J.N. Keller, A.M. Eleuteri, Natural polyphenols as proteasome modulators and their role as anti-cancer compounds, FEBS J. 275 (2008) 5512-5526.
10. J. Adams, Potential for proteasome inhibition in the treatment of cancer, Drug Discov. Today 8 (2003) 307-315. (Pubitemid 36332222)
11. H. Yang, J.A. Zonder, Q.P. Dou, Clinical development of novel proteasome inhibitors for cancer treatment, Expert. Opin. Investig. Drugs 18 (2009) 957-971.
12. I. Zavrski, C. Naujokat, K. Niemoller, C. Jakob, U. Heider, C. Langelotz, C. Fleissner, J. Eucker, K. Possinger, O. Sezer, Proteasome inhibitors induce growth inhibition and apoptosis in myeloma cell lines and in human bone marrow myeloma cells irrespective of chromosome 13 deletion, J. Cancer. Res. Clin. Oncol. 129 (2003) 383-391. (Pubitemid 36995137)
13. L. Borissenko, M. Groll, 20S proteasome and its inhibitors: crystallographic knowledge for drug development, Chem. Rev. 107 (2007) 687-717.
14. M. Groll, R. Huber, L. Moroder, The persisting challenge of selective and specific proteasome inhibition, J. Pept. Sci. 15 (2009) 58-66.
15. S. Shankar, S. Ganapathy, R.K. Srivastava, Green tea polyphenols: biology and therapeutic implications in cancer, Front. Biosci. 12 (2007) 4881-4899.
16. S. Mandel, M.B. Youdim, Catechin polyphenols: neurodegeneration and neuroprotection in neurodegenerative diseases, Free Radic. Biol. Med. 37 (2004) 304-317. (Pubitemid 38833997)
17. S. Nam, D.M. Smith, Q.P. Dou, Ester bond-containing tea polyphenols potently inhibit proteasome activity in vitro and in vivo, J. Biol. Chem. 276 (2001) 13322-13330.
18. D.M. Smith, K.G. Daniel, Z. Wang, W.C. Guida, T.H. Chan, Q.P. Dou, Docking studies and model development of tea polyphenol proteasome inhibitors: applications to rational drug design, Proteins 54 (2004) 58-70. (Pubitemid 38036915)
19. S. Sang, I. Yang, B. Buckley, C.T. Ho, C.S. Yang, Autoxidative quinone formation in vitro and metabolite formation in vivo from tea polyphenol (-)- epigallocatechin-3-gallate: studied by real-time mass spectrometry combined with tandem mass ion mapping, Free Radic. Biol. Med. 43 (2007) 362-371. (Pubitemid 46977623)
20. Y. Mizooku, M. Yoshikawa, T. Tsuneyoshi, R. Arakawa, Analysis of oxidized epigallocatechin gallate by liquid chromatography/mass spectrometry, Rapid Commun. Mass Spectrom. 17 (2003) 1915-1918.
21. S. Balasubramanian, R.L. Eckert, Green tea polyphenol and curcumin inversely regulate human involucrin promoter activity via opposing effects on CCAAT/ enhancer-binding protein function, J. Biol. Chem. 279 (2004) 24007-24014.
22. D.J. Kuhn, A.C. Burns, A. Kazi, Q.P. Dou, Direct inhibition of the ubiquitin-proteasome pathway by ester bond-containing green tea polyphenols is associated with increased expression of sterol regulatory element-binding protein 2 and LDL receptor, Biochim. Biophys. Acta 1682 (2004) 1-10.
23. M. Spina, M. Cuccioloni, M. Mozzicafreddo, F. Montecchia, S. Pucciarelli, A.M. Eleuteri, E. Fioretti, M. Angeletti, Mechanism of inhibition of wt-dihydrofolate reductase from E. coli by tea epigallocatechin-gallate, Proteins 72 (2008) 240-251. (Pubitemid 351809162)
24. E. Navarro-Peran, J. Cabezas-Herrera, F. Garcia-Canovas, M.C. Durrant, R.N. Thorneley, J.N. Rodriguez-Lopez, The antifolate activity of tea catechins, Cancer Res. 65 (2005) 2059-2064. (Pubitemid 40490108)
25. S. Sang, M.J. Lee, Z. Hou, C.T. Ho, C.S. Yang, Stability of tea polyphenol (-)-epigallocatechin-3-gallate and formation of dimers and epimers under common experimental conditions, J. Agric. Food Chem. 53 (2005) 9478-9484.
26. J. Hong, H. Lu, X. Meng, J.H. Ryu, Y. Hara, C.S. Yang, Stability, cellular uptake, biotransformation, and efflux of tea polyphenol (-)-epigallocatechin-3-gallate in HT-29 human colon adenocarcinoma cells, Cancer Res. 62 (2002) 7241-7246.
27. Z. Hou, S. Sang, H. You, M.J. Lee, J. Hong, K.V. Chin, C.S. Yang, Mechanism of action of (-)-epigallocatechin-3-gallate: auto-oxidation-dependent inactivation of epidermal growth factor receptor and direct effects on growth inhibition in human esophageal cancer KYSE 150 cells, Cancer Res. 65 (2005) 8049-8056. (Pubitemid 41297287)
28. K. Yoshino, M. Suzuki, K. Sasaki, T. Miyase, M. Sano, Formation of antioxidants from (-)-epigallocatechin gallate in mild alkaline fluids, such as authentic intestinal juice and mouse plasma, J. Nutr. Biochem. 10 (1999) 223-229.
29. S. Sang, J.D. Lambert, J. Hong, S. Tian, M.J. Lee, R.E. Stark, C.T. Ho, C.S. Yang, Synthesis and structure identification of thiol conjugates of (-)-epigallocatechin gallate and their urinary levels in mice, Chem. Res. Toxicol. 18 (2005) 1762-1769. (Pubitemid 43257759)
30. N. Zhu, T.C. Huang, Y. Yu, E.J. LaVoie, C.S. Yang, C.T. Ho, Identification of oxidation products of (-)-epigallocatechin gallate and (-)-epigallocatechin with H(2)O(2), J. Agric. Food Chem. 48 (2000) 979-981.
31. X. Meng, S. Sang, N. Zhu, H. Lu, S. Sheng, M.J. Lee, C.T. Ho, C.S. Yang, Identification and characterization of methylated and ring-fission metabolites of tea catechins formed in humans, mice, and rats, Chem. Res. Toxicol. 15 (2002) 1042-1050.
32. A.M. Eleuteri, M. Angeletti, G. Lupidi, R. Tacconi, L. Bini, E. Fioretti, Isolation and characterization of bovine thymus multicatalytic proteinase complex, Protein Expr. Purif. 18 (2000) 160-168.
33. M. Mozzicafreddo, M. Cuccioloni, A.M. Eleuteri, E. Fioretti, M. Angeletti, Flavonoids inhibit the amidolytic activity of human thrombin, Biochimie 88 (2006) 1297-1306. (Pubitemid 44415203)
34. W.F. Polik, J.R. Schmidt, WebMO: visualizing computational chemistry on the world wide web, Abs. Paper. Am. Chem. Soc. 222 (2001) U181-U181.
35. M. Unno, T. Mizushima, Y. Morimoto, Y. Tomisugi, K. Tanaka, N. Yasuoka, T. Tsukihara, The structure of themammalian 20S proteasome at 2.75 A resolution, Structure 10 (2002) 609-618. (Pubitemid 34518706)
36. M. Mozzicafreddo, M. Cuccioloni, V. Cecarini, A.M. Eleuteri, M. Angeletti, Homologymodeling and docking analysis of the interactionbetweenpolyphenols and mammalian 20S proteasomes, J. Chem. Inf. Model. 49 (2009) 401-409.
37. M.M. Bradford, A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding, Anal. Biochem. 72 (1976) 248-254.
38. K.R. Landis-Piwowar, S.B. Wan, R.A. Wiegand, D.J. Kuhn, T.H. Chan, Q.P. Dou, Methylation suppresses the proteasome-inhibitory function of green tea polyphenols, J. Cell. Physiol. 213 (2007) 252-260.
39. T. Mosmann, Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays, J. Immunol. Methods 65 (1983) 55-63. (Pubitemid 14203433)
40. C. Marchini, M. Angeletti, A.M. Eleuteri, A. Fedeli, E. Fioretti, Aspirin modulates LPS-induced nitric oxide release in rat glial cells,Neurosci. Lett. 381 (2005) 86-91. (Pubitemid 40693147)
41. I. Romero-Calvo, B. Ocon, P. Martinez-Moya, M.D. Suarez, A. Zarzuelo, O. Martinez-Augustin, F.S. de Medina, Reversible Ponceau staining as a loading control alternative to actin in western blots, Anal. Biochem. 401 318-320.
42. G. Vescovo, B. Ravara, L. Dalla Libera, Skeletal muscle myofibrillar protein oxidation and exercise capacity in heart failure, Basic Res. Cardiol. 103 (2008) 285-290.
43. I.N. Papadoyannis, H.G. Gika, Peak purity determination with a diode array detector, J. Liq. Chromatograph. Relat. Technol. 27 (2005) 1083-1092.
44. O. Aktas, T. Prozorovski, A. Smorodchenko, N.E. Savaskan, R. Lauster, P.M. Kloetzel, C. Infante-Duarte, S. Brocke, F. Zipp, Green tea epigallocatechin-3-gallate mediates T cellular NF-kappa B inhibition and exerts neuroprotection in autoimmune encephalomyelitis, J. Immunol. 173 (2004) 5794-5800. (Pubitemid 39392169)
45. A. Pettinari, M. Amici, M. Cuccioloni, M. Angeletti, E. Fioretti, A.M. Eleuteri, Effect of polyphenolic compounds on the proteolytic activities of constitutive and immuno-proteasomes, Antioxid. Redox Signal. 8 (2006) 121-129.
46. U. Ullmann, J. Haller, J.P. Decourt, N. Girault, J. Girault, A.S. Richard-Caudron, B. Pineau, P. Weber, A single ascending dose study of epigallocatechin gallate in healthy volunteers, J. Int. Med. Res. 31 (2003) 88-101. (Pubitemid 36553307)
47. H.C. Drexler, The role of p27Kip1 in proteasome inhibitor induced apoptosis, Cell Cycle 2 (2003) 438-441.
48. A.S. Baldwin Jr., The NF-kappa B and I kappa B proteins: new discoveries and insights, Annu. Rev. Immunol. 14 (1996) 649-683. (Pubitemid 26130197)
49. P. Tsvetkov, N. Reuven, C. Prives, Y. Shaul, The susceptibility of the p53 unstructured N-terminus to 20S proteasomal degradation programs stress response, J. Biol. Chem. (2009).
50. P.T. Schumacker, Reactive oxygen species in cancer cells: live by the sword, die by the sword, Cancer Cell 10 (2006) 175-176. (Pubitemid 44311072)
51. H. Lu, X. Meng, C.S. Yang, Enzymology of methylation of tea catechins and inhibition of catechol-O-methyltransferase by (-)-epigallocatechin gallate, Drug Metab. Dispos. 31 (2003) 572-579.
52. K. Okushio, M. Suzuki, N. Matsumoto, F. Nanjo, Y. Hara, Methylation of tea catechins by rat liver homogenates, Biosci. Biotechnol. Biochem. 63 (1999) 430-432. (Pubitemid 129548698)
53. K.R. Landis-Piwowar, C. Huo, D. Chen, V. Milacic, G. Shi, T.H. Chan, Q.P. Dou, A novel prodrug of the green tea polyphenol (-)-epigallocatechin-3-gallate as a potential anticancer agent, Cancer Res. 67 (2007) 4303-4310. (Pubitemid 46815078)
54. K.C. Anderson, Proteasome inhibitors in multiple myeloma, Semin. Oncol. 36 (2009) S20-S26.
55. W. Baumeister, J. Walz, F. Zuhl, E. Seemuller, The proteasome: paradigm of a self-compartmentalizing protease, Cell 92 (1998) 367-380. (Pubitemid 28093014)
56. C. Nakanishi, M. Toi, Nuclear factor-kappaB inhibitors as sensitizers to anticancer drugs, Nat. Rev. Cancer 5 (2005) 297-309.
57. C.S. Yang, J.D. Lambert, J. Ju, G. Lu, S. Sang, Tea and cancer prevention: molecular mechanisms and human relevance, Toxicol. Appl. Pharmacol. 224 (2007) 265-273. (Pubitemid 47592860)